A Web-mediated Follow-up With the Web-application KidneyPRO Versus Standard Follow-up for Patients With Advanced Renal Cell Carcinoma Treated With Axitinib/Pembrolizumab in First Line

Clinical trial NCT04764487 · UNKNOWN

Trial details

NCT number: NCT04764487
Sponsor: Weprom
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Renal Cell Carcinoma Metastatic

Start date: 2021-06-07
Primary completion: 2023-06-07
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.